Compare VTIX & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VTIX | CPIX |
|---|---|---|
| Founded | 2013 | 1999 |
| Country | United States | United States |
| Employees | 39 | N/A |
| Industry | Computer peripheral equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.9M | 92.3M |
| IPO Year | N/A | 2007 |
| Metric | VTIX | CPIX |
|---|---|---|
| Price | $1.51 | $6.72 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 690.1K | 115.7K |
| Earning Date | 08-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 58.70 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $42,010,949.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 16.75 |
| 52 Week Low | $1.45 | $1.85 |
| 52 Week High | $9.00 | $8.09 |
| Indicator | VTIX | CPIX |
|---|---|---|
| Relative Strength Index (RSI) | 28.92 | 50.29 |
| Support Level | N/A | $5.59 |
| Resistance Level | $4.51 | $7.72 |
| Average True Range (ATR) | 0.36 | 0.77 |
| MACD | -0.11 | -0.12 |
| Stochastic Oscillator | 6.85 | 38.03 |
Virtuix Holdings Inc pioneers movement in AI-generated worlds, both imaginary and real. The company is the creator of Omni, a brand of omni-directional treadmills that enable users to walk and run in 360 degrees inside virtual reality (VR) games, digital twins, and other applications. Its technology operates at the intersection of gaming, fitness, and enterprise VR. Its products include Omni Pro, Omni Arena, and Omni One. Its business integrates a consumer and enterprise VR hardware platform anchored by its flagship Omni One product with a defense-oriented simulation system, Virtual Terrain Walk (VTW), targeting next-generation immersive mission planning.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.